Literature DB >> 17459424

Effects of L-arginine on cerebral blood flow, microvascular permeability, number of perfused capillaries, and brain water content in the traumatized mouse brain.

C Lundblad1, P Bentzer.   

Abstract

It is has been suggested that decreased production of the vasodilatory and anti-aggregative substance NO (nitric oxide) may result in lower cerebral blood flow (CBF) in injured areas of the traumatized brain. The NO-precursor L-arginine has been shown to counteract CBF decreases early after trauma, but microcirculatory and more long-term effects on CBF of L-arginine have not been investigated. In an attempt to analyze effects of L-arginine on the microcirculation in the traumatized brain, the present study was designed to evaluate the effects of L-arginine compared to vehicle (0.9% saline) following a standardized controlled cortical-impact brain trauma in mice. Cerebral blood flow (autoradiography [(14)C]-iodoantipyrine), number of perfused capillaries (FITC-dextran fluorescence technique), brain water content (wet vs. dry weight) and the blood to brain transfer constant K(i) for [(51)Cr]-EDTA were analyzed in the injured and the contralateral cortex. Cortical blood flow in the injured cortex was 0.43+/-0.3 mL/g/min and 0.81+/-0.3 mL/g/min 3 h after trauma in the vehicle and L-arginine groups, respectively (p<0.05), and no treatment effect was seen 24 h after trauma. The number of perfused capillaries decreased following trauma and was unaffected by L-arginine. K(i) increased following trauma and was unaffected by L-arginine. Brain water content was lower in the L-arginine group than in the vehicle group 3 h after trauma and there was no difference between the groups 24 h after trauma. We conclude that L-arginine reduces brain edema formation and improves cortical blood flow in the early phase after a brain trauma, whereas no circulatory effects can be seen after prolonged treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459424     DOI: 10.1016/j.mvr.2007.03.001

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  8 in total

1.  Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.

Authors:  Xinli Hu; Dorothee Atzler; Xin Xu; Ping Zhang; Haipeng Guo; Zhongbing Lu; John Fassett; Edzard Schwedhelm; Rainer H Böger; Robert J Bache; Yingjie Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

2.  L-arginine reactivity in cerebral vessels after severe traumatic brain injury.

Authors:  Leonardo Rangel-Castilla; Osama Ahmed; J Clay Goodman; Shankar Gopinath; Alex Valadka; Claudia Robertson
Journal:  Neurol Res       Date:  2010-08-16       Impact factor: 2.448

3.  Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway.

Authors:  Rishab Mehta; Ranjana Bhandari; Anurag Kuhad
Journal:  Psychopharmacology (Berl)       Date:  2021-08-27       Impact factor: 4.415

4.  Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice.

Authors:  Nicole A Terpolilli; Seong-Woong Kim; Serge C Thal; Wolfgang M Kuebler; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-28       Impact factor: 6.200

5.  Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's diseases in Balb/c mice.

Authors:  Javad Hami; Mehran Hosseini; Sekineh Shahi; Nassim Lotfi; Abolfazl Talebi; Mohammad Afshar
Journal:  Iran J Neurol       Date:  2015-10-07

6.  Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice.

Authors:  Javad Hami; Mehran Hosseini; Saeed Vafaei Nezhad; Sekineh Shahi; Nassim Lotfi; Hossein Ehsani; Akram Sadeghi
Journal:  Adv Biomed Res       Date:  2016-08-30

Review 7.  Vitamin C and Cardiovascular Disease: An Update.

Authors:  Marco B Morelli; Jessica Gambardella; Vanessa Castellanos; Valentina Trimarco; Gaetano Santulli
Journal:  Antioxidants (Basel)       Date:  2020-12-03

8.  Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure.

Authors:  Cornelius Engelmann; Danielle Adebayo; Marc Oria; Francesco De Chiara; Simone Novelli; Abeba Habtesion; Nathan Davies; Fausto Andreola; Rajiv Jalan
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.